SPONSOR
Alexion Pharmaceuticals, Inc.
Total Trials
3
Recruiting
3
Phases
Phase 3
Conditions studied: Generalized Myasthenia GravisAnti-AChR Antibody PositiveIgANIgAVNImmunoglobulin A NephropathyImmunoglobulin A Vasculitis Associated NephritisHenoch-schonlein Purpura NephritisIgA VasculitisUltomiris-exposed Pregnant/ PostpartumPregnancy
Alexion Pharmaceuticals, Inc. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Generalized Myasthenia Gravis, Anti-AChR Antibody Positive, IgAN, IgAVN.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Alexion Pharmaceuticals, Inc.
How many clinical trials has Alexion Pharmaceuticals, Inc. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Alexion Pharmaceuticals, Inc., of which 3 are actively recruiting participants. These trials cover conditions including Generalized Myasthenia Gravis, Anti-AChR Antibody Positive, IgAN. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Alexion Pharmaceuticals, Inc. research focus on?
Alexion Pharmaceuticals, Inc. clinical trials span Generalized Myasthenia Gravis, Anti-AChR Antibody Positive, IgAN, IgAVN, Immunoglobulin A Nephropathy, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Alexion Pharmaceuticals, Inc. clinical trial?
To participate in a Alexion Pharmaceuticals, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Alexion Pharmaceuticals, Inc. trials with current recruitment status updated daily.
Clinical Trials by Alexion Pharmaceuticals, Inc.
NCT06967480
Recruiting
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
NCT07024563 Phase 3
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
IgAN
NCT06312644
Recruiting
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Ultomiris-exposed Pregnant/ Postpartum
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology